Tina Montee
Family · Sullivan, MONPI 1942616016
Payments from drug & device makers
Across 177 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$931
- Novo Nordisk$386
- Novartis$188
- Amgen$159
- Pfizer$131
- AstraZeneca$128
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,27597%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $931 |
| Novo Nordisk | 25 | $386 |
| Novartis | 10 | $188 |
| Amgen | 10 | $159 |
| Pfizer | 7 | $131 |
| AstraZeneca | 9 | $128 |
| Otsuka America Pharmaceutical, Inc. | 5 | $127 |
| Lilly USA, LLC | 6 | $125 |
| Boehringer Ingelheim | 7 | $120 |
| Astellas Pharma US Inc | 2 | $119 |
| Dexcom, Inc. | 4 | $88 |
| Bayer | 4 | $74 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $72 |
| Edwards Lifesciences | 3 | $69 |
| GSK | 4 | $64 |
| Radius Health, Inc. | 2 | $62 |
| Abbott | 2 | $46 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| Lundbeck LLC | 2 | $45 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Johnson & Johnson | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Apria Healthcare LLC | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Valinor Pharma, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$3,375 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 48 | $53,746 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $38,445 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $11,854 |
| XareltoRivaroxaban | 13 | $10,469 |
| JardianceEmpagliflozin | 17 | $9,513 |
| MyrbetriqMirabegron | 20 | $9,142 |
| EliquisApixaban | 11 | $8,792 |
| FarxigaDapagliflozin Propanediol | 13 | $7,912 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,883 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 103 | $2,518 |
| Atorvastatin Calcium | 102 | $1,362 |
| Levothyroxine Sodium | 83 | $1,292 |
| Omeprazole | 87 | $1,182 |
| Celecoxib | 19 | $1,030 |
| Gabapentin | 48 | $986 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $64 | $56,18287 claims |
| Novo NordiskOzempic | $386 | $53,74648 claims |
| Johnson & JohnsonXarelto | $30 | $10,46913 claims |
| Boehringer IngelheimJardiance | $120 | $9,51317 claims |
| Astellas Pharma US IncMyrbetriq | $119 | $9,14220 claims |
| PfizerEliquis | $131 | $8,79211 claims |
| AstraZenecaFarxiga | $128 | $7,91213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.
Other family in Sullivan
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.